135 related articles for article (PubMed ID: 10751109)
1. Olfaction in Parkinson's disease: methods of assessment and clinical relevance.
Liberini P; Parola S; Spano PF; Antonini L
J Neurol; 2000 Feb; 247(2):88-96. PubMed ID: 10751109
[TBL] [Abstract][Full Text] [Related]
2. Assessing olfaction in the Italian population: methodology and clinical application.
Parola S; Liberini P
Ital J Neurol Sci; 1999 Oct; 20(5):287-96. PubMed ID: 10933437
[TBL] [Abstract][Full Text] [Related]
3. Correlation between progressive changes in piriform cortex and olfactory performance in early Parkinson's disease.
Wu X; Yu C; Fan F; Zhang K; Zhu C; Wu T; Li K; Chan P
Eur Neurol; 2011; 66(2):98-105. PubMed ID: 21846992
[TBL] [Abstract][Full Text] [Related]
4. Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease.
Doty RL; Golbe LI; McKeown DA; Stern MB; Lehrach CM; Crawford D
Neurology; 1993 May; 43(5):962-5. PubMed ID: 8492953
[TBL] [Abstract][Full Text] [Related]
5. Olfactory dysfunction as a diagnostic marker for Parkinson's disease.
Haehner A; Hummel T; Reichmann H
Expert Rev Neurother; 2009 Dec; 9(12):1773-9. PubMed ID: 19951136
[TBL] [Abstract][Full Text] [Related]
6. Correlation among olfactory function, motors' symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson's disease.
Masala C; Solla P; Liscia A; Defazio G; Saba L; Cannas A; Cavazzana A; Hummel T; Haehner A
J Neurol; 2018 Aug; 265(8):1764-1771. PubMed ID: 29804147
[TBL] [Abstract][Full Text] [Related]
7. Olfactory Dysfunction as an Early Biomarker in Parkinson's Disease.
Fullard ME; Morley JF; Duda JE
Neurosci Bull; 2017 Oct; 33(5):515-525. PubMed ID: 28831680
[TBL] [Abstract][Full Text] [Related]
8. Olfactory impairment in Parkinson's disease and white matter abnormalities in central olfactory areas: A voxel-based diffusion tensor imaging study.
Ibarretxe-Bilbao N; Junque C; Marti MJ; Valldeoriola F; Vendrell P; Bargallo N; Zarei M; Tolosa E
Mov Disord; 2010 Sep; 25(12):1888-94. PubMed ID: 20669268
[TBL] [Abstract][Full Text] [Related]
9. In vivo neurochemical imaging of olfactory dysfunction in Parkinson's disease.
Bohnen NI; Müller ML
J Neural Transm (Vienna); 2013 Apr; 120(4):571-6. PubMed ID: 23263541
[TBL] [Abstract][Full Text] [Related]
10. Olfactory dysfunctions in drug-naïve Parkinson's disease with mild cognitive impairment.
Park JW; Kwon DY; Choi JH; Park MH; Yoon HK
Parkinsonism Relat Disord; 2018 Jan; 46():69-73. PubMed ID: 29233469
[TBL] [Abstract][Full Text] [Related]
11. Detection of preclinical Parkinson's disease along the olfactory trac(t).
Berendse HW; Ponsen MM
J Neural Transm Suppl; 2006; (70):321-5. PubMed ID: 17017547
[TBL] [Abstract][Full Text] [Related]
12. Chemosensory event-related potentials in response to trigeminal and olfactory stimulation in idiopathic Parkinson's disease.
Barz S; Hummel T; Pauli E; Majer M; Lang CJ; Kobal G
Neurology; 1997 Nov; 49(5):1424-31. PubMed ID: 9371933
[TBL] [Abstract][Full Text] [Related]
13. [Olfactory dysfunction in Parkinson's disease: its role as a new cardinal sign in early and differential diagnosis].
Herting B; Bietenbeck S; Scholz K; Hähner A; Hummel T; Reichmann H
Nervenarzt; 2008 Feb; 79(2):175-84. PubMed ID: 17701389
[TBL] [Abstract][Full Text] [Related]
14. Olfactory dysfunction in Parkinson's disease.
Wszolek ZK; Markopoulou K
Clin Neurosci; 1998; 5(2):94-101. PubMed ID: 10785834
[TBL] [Abstract][Full Text] [Related]
15. Brain infusion of α-synuclein oligomers induces motor and non-motor Parkinson's disease-like symptoms in mice.
Fortuna JTS; Gralle M; Beckman D; Neves FS; Diniz LP; Frost PS; Barros-Aragão F; Santos LE; Gonçalves RA; Romão L; Zamberlan DC; Soares FAA; Braga C; Foguel D; Gomes FCA; De Felice FG; Ferreira ST; Clarke JR; Figueiredo CP
Behav Brain Res; 2017 Aug; 333():150-160. PubMed ID: 28668282
[TBL] [Abstract][Full Text] [Related]
16. A clinical approach towards smell loss in Parkinson's disease.
Haehner A; Hummel T; Reichmann H
J Parkinsons Dis; 2014; 4(2):189-95. PubMed ID: 24322062
[TBL] [Abstract][Full Text] [Related]
17. Olfactory dysfunction in early Parkinson's disease is associated with short latency afferent inhibition reflecting central cholinergic dysfunction.
Oh E; Park J; Youn J; Kim JS; Park S; Jang W
Clin Neurophysiol; 2017 Jun; 128(6):1061-1068. PubMed ID: 28400098
[TBL] [Abstract][Full Text] [Related]
18. Parkinson's disease: clinical aspects.
Klockgether T
Cell Tissue Res; 2004 Oct; 318(1):115-20. PubMed ID: 15365814
[TBL] [Abstract][Full Text] [Related]
19. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.
Stiasny-Kolster K; Doerr Y; Möller JC; Höffken H; Behr TM; Oertel WH; Mayer G
Brain; 2005 Jan; 128(Pt 1):126-37. PubMed ID: 15548552
[TBL] [Abstract][Full Text] [Related]
20. Olfactory tests as possible probes for detecting and monitoring Alzheimer's disease.
Kesslak JP; Cotman CW; Chui HC; Van den Noort S; Fang H; Pfeffer R; Lynch G
Neurobiol Aging; 1988; 9(4):399-403. PubMed ID: 3185859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
